Edesa Biotech Stock Technical Analysis
| EDSA Stock | USD 4.35 2.07 90.79% |
As of the 4th of March, Edesa Biotech shows the Mean Deviation of 7.17, coefficient of variation of 675.93, and Downside Deviation of 5.59. Edesa Biotech technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.
Edesa Biotech Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Edesa, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to EdesaEdesa Biotech's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Edesa Biotech Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 11.0 | Strong Buy | 1 | Odds |
Most Edesa analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Edesa stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Edesa Biotech, talking to its executives and customers, or listening to Edesa conference calls.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Edesa Biotech. Projected growth potential of Edesa fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Edesa Biotech assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Investors evaluate Edesa Biotech using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Edesa Biotech's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Edesa Biotech's market price to deviate significantly from intrinsic value.
It's important to distinguish between Edesa Biotech's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Edesa Biotech should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Edesa Biotech's market price signifies the transaction level at which participants voluntarily complete trades.
Edesa Biotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Edesa Biotech's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Edesa Biotech.
| 12/04/2025 |
| 03/04/2026 |
If you would invest 0.00 in Edesa Biotech on December 4, 2025 and sell it all today you would earn a total of 0.00 from holding Edesa Biotech or generate 0.0% return on investment in Edesa Biotech over 90 days. Edesa Biotech is related to or competes with BioRestorative Therapies, Dogwood Therapeutics, Cocrystal Pharma, OSR Holdings, Traws Pharma, Immuron, and Eterna Therapeutics. Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage d... More
Edesa Biotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Edesa Biotech's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Edesa Biotech upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.59 | |||
| Information Ratio | 0.1449 | |||
| Maximum Drawdown | 77.71 | |||
| Value At Risk | (9.09) | |||
| Potential Upside | 13.97 |
Edesa Biotech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Edesa Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Edesa Biotech's standard deviation. In reality, there are many statistical measures that can use Edesa Biotech historical prices to predict the future Edesa Biotech's volatility.| Risk Adjusted Performance | 0.121 | |||
| Jensen Alpha | 2.39 | |||
| Total Risk Alpha | 1.54 | |||
| Sortino Ratio | 0.405 | |||
| Treynor Ratio | (0.93) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Edesa Biotech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Edesa Biotech March 4, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.121 | |||
| Market Risk Adjusted Performance | (0.92) | |||
| Mean Deviation | 7.17 | |||
| Semi Deviation | 4.37 | |||
| Downside Deviation | 5.59 | |||
| Coefficient Of Variation | 675.93 | |||
| Standard Deviation | 15.63 | |||
| Variance | 244.34 | |||
| Information Ratio | 0.1449 | |||
| Jensen Alpha | 2.39 | |||
| Total Risk Alpha | 1.54 | |||
| Sortino Ratio | 0.405 | |||
| Treynor Ratio | (0.93) | |||
| Maximum Drawdown | 77.71 | |||
| Value At Risk | (9.09) | |||
| Potential Upside | 13.97 | |||
| Downside Variance | 31.3 | |||
| Semi Variance | 19.07 | |||
| Expected Short fall | (10.42) | |||
| Skewness | 4.23 | |||
| Kurtosis | 20.14 |
Edesa Biotech Backtested Returns
Edesa Biotech is dangerous given 3 months investment horizon. Edesa Biotech secures Sharpe Ratio (or Efficiency) of 0.15, which denotes the company had a 0.15 % return per unit of risk over the last 3 months. We are able to interpolate and collect twenty-nine different technical indicators, which can help you to evaluate if expected returns of 2.53% are justified by taking the suggested risk. Use Edesa Biotech Coefficient Of Variation of 675.93, mean deviation of 7.17, and Downside Deviation of 5.59 to evaluate company specific risk that cannot be diversified away. Edesa Biotech holds a performance score of 12 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -2.47, which means a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Edesa Biotech are expected to decrease by larger amounts. On the other hand, during market turmoil, Edesa Biotech is expected to outperform it. Use Edesa Biotech maximum drawdown, skewness, and the relationship between the total risk alpha and downside variance , to analyze future returns on Edesa Biotech.
Auto-correlation | 0.00 |
No correlation between past and present
Edesa Biotech has no correlation between past and present. Overlapping area represents the amount of predictability between Edesa Biotech time series from 4th of December 2025 to 18th of January 2026 and 18th of January 2026 to 4th of March 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Edesa Biotech price movement. The serial correlation of 0.0 indicates that just 0.0% of current Edesa Biotech price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | -0.16 | |
| Residual Average | 0.0 | |
| Price Variance | 0.41 |
Edesa Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Edesa Biotech Technical Analysis
The output start index for this execution was two with a total number of output elements of fifty-nine. The Normalized Average True Range is used to analyze tradable apportunities for Edesa Biotech across different markets.
About Edesa Biotech Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Edesa Biotech on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Edesa Biotech based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Edesa Biotech price pattern first instead of the macroeconomic environment surrounding Edesa Biotech. By analyzing Edesa Biotech's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Edesa Biotech's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Edesa Biotech specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2025 | 2026 (projected) | Days Sales Outstanding | 63.81 | 92.27 | PTB Ratio | 109.59 | 115.07 |
Edesa Biotech March 4, 2026 Technical Indicators
Most technical analysis of Edesa help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Edesa from various momentum indicators to cycle indicators. When you analyze Edesa charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.121 | |||
| Market Risk Adjusted Performance | (0.92) | |||
| Mean Deviation | 7.17 | |||
| Semi Deviation | 4.37 | |||
| Downside Deviation | 5.59 | |||
| Coefficient Of Variation | 675.93 | |||
| Standard Deviation | 15.63 | |||
| Variance | 244.34 | |||
| Information Ratio | 0.1449 | |||
| Jensen Alpha | 2.39 | |||
| Total Risk Alpha | 1.54 | |||
| Sortino Ratio | 0.405 | |||
| Treynor Ratio | (0.93) | |||
| Maximum Drawdown | 77.71 | |||
| Value At Risk | (9.09) | |||
| Potential Upside | 13.97 | |||
| Downside Variance | 31.3 | |||
| Semi Variance | 19.07 | |||
| Expected Short fall | (10.42) | |||
| Skewness | 4.23 | |||
| Kurtosis | 20.14 |
Edesa Biotech March 4, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Edesa stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 12,584,778 | ||
| Daily Balance Of Power | 1.07 | ||
| Rate Of Daily Change | 1.91 | ||
| Day Median Price | 3.39 | ||
| Day Typical Price | 3.71 | ||
| Price Action Indicator | 2.00 |
Complementary Tools for Edesa Stock analysis
When running Edesa Biotech's price analysis, check to measure Edesa Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edesa Biotech is operating at the current time. Most of Edesa Biotech's value examination focuses on studying past and present price action to predict the probability of Edesa Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edesa Biotech's price. Additionally, you may evaluate how the addition of Edesa Biotech to your portfolios can decrease your overall portfolio volatility.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |